Carbapenem Resistance: A Review

Overview

Journal Med Sci (Basel)

Specialty General Medicine

Date 2017 Dec 22

PMID 29267233

Citations 287

Authors

Francis S Codjoe

Eric S Donkor

Affiliations

Soon will be listed here.

Abstract

Carbapenem resistance is a major and an on-going public health problem globally. It occurs mainly among Gram-negative pathogens such as , and baumannii, and may be intrinsic or mediated by transferable carbapenemase-encoding genes. This type of resistance genes are already widespread in certain parts of the world, particularly Europe, Asia and South America, while the situation in other places such as sub-Saharan Africa is not well documented. In this paper, we provide an in-depth review of carbapenem resistance providing up-to-date information on the subject.

Citing Articles

Parallel Detection of the Unamplified Carbapenem Resistance Genes and Using a Plasmonic Nano-Biosensor with a Field-Portable DNA Extraction Method.

Kao K, Alocilja E Biosensors (Basel). 2025; 15(2).

PMID: 39997014 PMC: 11853256. DOI: 10.3390/bios15020112.

Risk Factors for Development and Mortality of Carbapenem-Resistant Bloodstream Infection in a Chinese Teaching Hospital: A Seven-Year Retrospective Study.

Dong L, Huang Y, Zhang S, Xu B, Li B, Cao Y Infect Drug Resist. 2025; 18:979-991.

PMID: 39990780 PMC: 11847577. DOI: 10.2147/IDR.S495240.

Mechanisms, therapeutic strategies, and emerging therapeutic alternatives for carbapenem resistance in Gram-negative bacteria.

Mourabiti F, Jouga F, Sakoui S, El Hosayny O, Zouheir Y, Soukri A Arch Microbiol. 2025; 207(3):58.

PMID: 39948320 DOI: 10.1007/s00203-025-04252-z.

Risk factors for Carbapenem-resistant Enterobacterales infections: A case-control study.

Mbele S, Vasaikar S S Afr Fam Pract (2004). 2025; 67(1):e1-e10.

PMID: 39935157 PMC: 11886460. DOI: 10.4102/safp.v67i1.6029.

Complete genome sequences of two verona integron-encoded metallo-ß-lactamase (VIM)-producing enterobacterales isolated from dogs in the United States.

Desai D, Cole S Microbiol Resour Announc. 2025; 14(3):e0089224.

PMID: 39907448 PMC: 11895491. DOI: 10.1128/mra.00892-24.

References

Poole K . Efflux-mediated antimicrobial resistance. J Antimicrob Chemother. 2005; 56(1):20-51. DOI: 10.1093/jac/dki171. View

Poirel L, Potron A, Nordmann P . OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother. 2012; 67(7):1597-606. DOI: 10.1093/jac/dks121. View

Hayes M, Orr D . Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother. 1983; 12(2):119-26. DOI: 10.1093/jac/12.2.119. View

Gaibani P, Colombo R, Arghittu M, Cariani L, Ambretti S, Bua G . Successful containment and infection control of a Carbapenem-resistant Klebsiella pneumoniae outbreak in an Italian hospital. New Microbiol. 2014; 37(1):87-90. View

Freifeld A, Bow E, Sepkowitz K, Boeckh M, Ito J, Mullen C . Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011; 52(4):e56-93. DOI: 10.1093/cid/cir073. View

Cuzon G, Naas T, Truong H, Villegas M, Wisell K, Carmeli Y . Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene. Emerg Infect Dis. 2010; 16(9):1349-56. PMC: 3294963. DOI: 10.3201/eid1609.091389. View

Schwaber M, Carmeli Y . Carbapenem-resistant Enterobacteriaceae: a potential threat. JAMA. 2008; 300(24):2911-3. DOI: 10.1001/jama.2008.896. View

Hagihara M, Housman S, Nicolau D, Kuti J . In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2013; 58(2):874-9. PMC: 3910875. DOI: 10.1128/AAC.01624-13. View

Curiao T, Morosini M, Ruiz-Garbajosa P, Robustillo A, Baquero F, Coque T . Emergence of bla KPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain. J Antimicrob Chemother. 2010; 65(8):1608-14. DOI: 10.1093/jac/dkq174. View

10.

Varadi L, Luo J, Hibbs D, Perry J, Anderson R, Orenga S . Methods for the detection and identification of pathogenic bacteria: past, present, and future. Chem Soc Rev. 2017; 46(16):4818-4832. DOI: 10.1039/c6cs00693k. View

11.

Queenan A, Shang W, Flamm R, Bush K . Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem. Antimicrob Agents Chemother. 2009; 54(1):565-9. PMC: 2798497. DOI: 10.1128/AAC.01004-09. View

12.

Castanheira M, Deshpande L, Mathai D, Bell J, Jones R, Mendes R . Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob Agents Chemother. 2010; 55(3):1274-8. PMC: 3067112. DOI: 10.1128/AAC.01497-10. View

13.

Gniadek T, Carroll K, Simner P . Carbapenem-Resistant Non-Glucose-Fermenting Gram-Negative Bacilli: the Missing Piece to the Puzzle. J Clin Microbiol. 2016; 54(7):1700-1710. PMC: 4922101. DOI: 10.1128/JCM.03264-15. View

14.

Livermore D, Hope R, Brick G, Lillie M, Reynolds R . Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother. 2008; 62 Suppl 2:ii55-63. DOI: 10.1093/jac/dkn352. View

15.

Yu E, McDermott G, Zgurskaya H, Nikaido H, Koshland Jr D . Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump. Science. 2003; 300(5621):976-80. DOI: 10.1126/science.1083137. View

16.

THYRUM P, Yeh C, Birmingham B, Lasseter K . Pharmacokinetics of meropenem in patients with liver disease. Clin Infect Dis. 1997; 24 Suppl 2:S184-90. DOI: 10.1093/clinids/24.supplement_2.s184. View

17.

Mandell L . Doripenem: a new carbapenem in the treatment of nosocomial infection. Clin Infect Dis. 2009; 49 Suppl 1:S1-3. DOI: 10.1086/599809. View

18.

Brink A, Coetzee J, Clay C, Corcoran C, van Greune J, Deetlefs J . The spread of carbapenem-resistant Enterobacteriaceae in South Africa: risk factors for acquisition and prevention. S Afr Med J. 2012; 102(7):599-601. DOI: 10.7196/samj.5789. View

19.

Muggeo A, Guillard T, Klein F, Reffuveille F, Francois C, Babosan A . Spread of Klebsiella pneumoniae ST395 non-susceptible to carbapenems and resistant to fluoroquinolones in North-Eastern France. J Glob Antimicrob Resist. 2017; 13:98-103. DOI: 10.1016/j.jgar.2017.10.023. View

20.

Woodford N, Turton J, Livermore D . Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev. 2011; 35(5):736-55. DOI: 10.1111/j.1574-6976.2011.00268.x. View